Drug Profile
Gemcitabine elaidate companion diagnostic - Roche Tissue Diagnostics
Alternative Names: hENT1 cancer diagnostic - Roche Tissue Diagnostics/Clovis Oncology; hENT1 Companion Diagnostic Test; hENT1 IHC assayLatest Information Update: 13 Jul 2021
Price :
$50
*
At a glance
- Originator Ventana Medical Systems
- Developer Clovis Oncology; Roche Tissue Diagnostics; Ventana Medical Systems
- Class Monoclonal antibodies; Monoclonal antibody diagnostics
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Pancreatic cancer
Most Recent Events
- 13 Jul 2021 Ventana Medical Systems is now called Roche Tissue Diagnostics
- 11 Nov 2013 No development reported - Clinical-Phase-Unknown for Pancreatic cancer in USA (unspecified route)
- 31 Dec 2010 Launched for Diagnostic tests in European Union (unspecified route)